盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300143 盈康生命

已收盘 01-13 15:00:00

{"stockData":{"symbol":"300143","market":"SZ","secType":"STK","nameCN":"盈康生命","latestPrice":13.2,"timestamp":1768287825000,"preClose":13.28,"halted":0,"volume":72748832,"delay":0,"changeRate":-0.006,"floatShares":641000000,"shares":749000000,"eps":0.1598,"marketStatus":"已收盘","change":-0.08,"latestTime":"01-13 15:00:00","open":13.56,"high":14.38,"low":13.18,"amount":999000000,"amplitude":0.0904,"askPrice":13.2,"askSize":4266,"bidPrice":13.19,"bidSize":179,"shortable":0,"etf":0,"ttmEps":0.1598,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":13.28,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":14.61,"lowLimit":11.95,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":749451604,"isCdr":false,"pbRate":3.94,"roa":"--","peRate":82.603254,"roe":"3.5%","epsLYR":0.18,"committee":-0.672261,"marketValue":9893000000,"turnoverRate":0.1134,"status":1,"floatMarketCap":8466000000},"requestUrl":"/m/hq/s/300143","defaultTab":"news","newsList":[{"id":"2603502156","title":"盈康生命(300143)1月9日股东户数2.62万户，较上期增加28.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603502156","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603502156?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:38","pubTimestamp":1768297110,"startTime":"0","endTime":"0","summary":"证券之星消息，近日盈康生命披露，截至2026年1月9日公司股东户数为2.62万户，较12月31日增加5860.0户，增幅为28.83%。在医疗服务行业个股中，盈康生命股东户数低于行业平均水平，截至1月9日，医疗服务行业平均股东户数为4.5万户。从股价来看，2025年12月31日至2026年1月9日，盈康生命区间涨幅为19.84%，在此期间股东户数增加5860.0户，增幅为28.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300029742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2602946325","title":"1月12日盈康生命涨12.16%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602946325","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602946325?lang=zh_cn&edition=full","pubTime":"2026-01-12 15:45","pubTimestamp":1768203950,"startTime":"0","endTime":"0","summary":"证券之星消息，1月12日盈康生命涨12.16%创60日新高，收盘报13.28元，换手率9.39%，成交量60.24万手，成交额7.84亿元。重仓盈康生命的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.56亿元，最新净值2.773，较上一交易日上涨2.67%，近一年上涨36.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200015321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2601356606","title":"1月8日盈康生命涨7.39%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601356606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601356606?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:38","pubTimestamp":1767857938,"startTime":"0","endTime":"0","summary":"证券之星消息，1月8日盈康生命涨7.39%创60日新高，收盘报11.62元，换手率7.09%，成交量45.46万手，成交额5.17亿元。重仓盈康生命的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A目前规模为1.56亿元，最新净值2.63，较上一交易日下跌1.02%，近一年上涨27.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2601133174","title":"盈康生命：提升经营质量实现可持续发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2601133174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601133174?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:34","pubTimestamp":1767843287,"startTime":"0","endTime":"0","summary":"公司高度重视市值管理和投资者回报，将企业价值视为市值管理的核心，致力于提升经营质量，实现长期可持续发展，并持续深化既有市值管理举措：严格遵守法律法规，确保公司运作的规范性；集中资源和精力于核心业务，增强公司在行业内的竞争优势；坚持稳健的经营策略，注重风险控制与长期发展；依法依规运用资本市场的各种工具和策略，增强公司的市场活力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800015064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2601080962","title":"盈康生命（300143）披露2025年度持续督导培训情况，1月7日股价下跌3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601080962","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601080962?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:13","pubTimestamp":1767795196,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，盈康生命报收于10.82元，较前一交易日下跌3.91%，最新总市值为81.09亿元。该股当日开盘11.26元，最高11.26元，最低10.77元，成交额达2.76亿元，换手率为3.92%。近日，国泰海通证券股份有限公司发布了关于盈康生命科技股份有限公司2025年度持续督导培训情况的报告。公告显示，作为盈康生命2020年非公开发行股票、2022年向特定对象发行股票的持续督导机构，国泰海通证券于2025年12月30日以现场和线上相结合的方式开展了2025年度持续督导培训。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700038749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2601842780","title":"盈康生命：已建立脑机接口治疗帕金森全流程管理方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2601842780","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601842780?lang=zh_cn&edition=full","pubTime":"2026-01-07 09:15","pubTimestamp":1767748517,"startTime":"0","endTime":"0","summary":"请问盈康生命在脑科学与脑机接口方面的规划，以及在脑机外科手术的技术储备有哪些？在临床实践方面，公司已建立起覆盖术前筛查、术中实施到术后监控、康复的脑机接口治疗帕金森全流程管理方案。公司旗下运城医院完成20余例脑起搏器植入术，为帕金森患者提供创新治疗方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700005582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2601892062","title":"盈康生命：向科技公司战略升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601892062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601892062?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:53","pubTimestamp":1767703987,"startTime":"0","endTime":"0","summary":"请问盈康生命在2026年有什么新的战略部署？公司正从“医疗服务与医疗器械双轮驱动的综合性医疗集团”向“为用户提供健康场景解决方案的科技公司”进行战略升级。公司将继续以肿瘤等核心专科领域为基石，并积极拓展居家健康等新场景，在深化现有“双轮驱动”业务协同的基础上，构建以科技创新为底座的健康管理平台，系统化地推进服务模式升级与价值链延伸。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600040123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2601000919","title":"盈康生命：截至2025年12月31日股东总数为20,327户","url":"https://stock-news.laohu8.com/highlight/detail?id=2601000919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601000919?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:18","pubTimestamp":1767608288,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)01月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止12月31日公司股东人数是多少？盈康生命回复：尊敬的投资者，您好！截至2025年12月31日，公司股东总数为20,327户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500028343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2593631854","title":"盈康生命：截至2025年12月19日股东总数为20,087户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593631854","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593631854?lang=zh_cn&edition=full","pubTime":"2025-12-23 11:37","pubTimestamp":1766461045,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月20日公司的股东人数是多少？谢谢盈康生命回复：尊敬的投资者，您好！截至2025年12月19日，公司股东总数为20,087户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300014834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2593799101","title":"【机构调研记录】天弘基金调研盈康生命、经纬恒润等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2593799101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593799101?lang=zh_cn&edition=full","pubTime":"2025-12-22 08:01","pubTimestamp":1766361688,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月19日披露的机构调研信息，天弘基金近期对3家上市公司进行了调研，相关名单如下：1）盈康生命 调研纪要：公司正从“医疗服务与医疗器械双轮驱动的综合性医疗集团”向“为用户提供健康场景解决方案的科技公司”演进，运用人工智能等技术提供全场景、全周期健康管理服务。3）中瓷电子 调研纪要：中瓷电子光模块配套产品预计明年持续放量，订单充足，产能利用率高，已积极扩产保障交付。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200000222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688326","BK0236","300143","BK0214"],"gpt_icon":0},{"id":"2592150298","title":"盈康生命：在差异化发展领域，公司医疗服务板块的布局主要围绕三个层面系统展开","url":"https://stock-news.laohu8.com/highlight/detail?id=2592150298","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592150298?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:40","pubTimestamp":1766133600,"startTime":"0","endTime":"0","summary":"证券日报网12月19日讯盈康生命在12月18日回答调研者提问时表示，在差异化发展领域，公司医疗服务板块的布局主要围绕以下三个层面系统展开：第一，在综合医疗服务领域，公司致力于拓展消费型健康产品与个性化服务，推动服务模式从传统疾病治疗向覆盖用户全生命周期的健康管理升级，以满足市场多元化需求。公司通过上述分层、聚焦的差异化布局，旨在构建更全面、更具韧性的医疗服务体系。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-19/doc-inhcipum2313998.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-19/doc-inhcipum2313998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2591642985","title":"盈康生命（300143）披露2023年限制性股票激励计划归属结果暨股份上市公告，12月15日股价上涨0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642985","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642985?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:25","pubTimestamp":1765808708,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，盈康生命报收于9.91元，较前一交易日上涨0.51%，最新总市值为74.27亿元。该股当日开盘9.86元，最高9.97元，最低9.8元，成交额达3079.78万元，换手率为0.48%。近日，盈康生命科技股份有限公司发布关于2023年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期归属结果暨股份上市的公告。本次归属不设限售期，董事及高管按相关规定执行股份转让限制。本次归属股份已于2025年12月15日上市流通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500035892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2590692573","title":"盈康生命：截至2025年12月10日股东总数为20,115户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590692573","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590692573?lang=zh_cn&edition=full","pubTime":"2025-12-12 15:03","pubTimestamp":1765523000,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)12月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最新的股东户数盈康生命回复：尊敬的投资者，您好！截至2025年12月10日，公司股东总数为20,115户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200018138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2590372495","title":"盈康生命：医疗器械数智产业园工程进度达69.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590372495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590372495?lang=zh_cn&edition=full","pubTime":"2025-12-10 11:37","pubTimestamp":1765337839,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命12月10日在投资者关系平台上答复投资者关心的问题。海尔大健康医疗器械数智产业园项目自开工以来，一直按照既定规划有序推进。根据公司2025年半年度报告，该项目工程进度已达69.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000014090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1574","BK1100","09997","BK1583","300143","BK0236","09996","BK1222"],"gpt_icon":0},{"id":"2589737383","title":"盈康生命：完成收购长沙珂信51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2589737383","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589737383?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:36","pubTimestamp":1765164998,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命12月08日在投资者关系平台上答复投资者关心的问题。马总公开讲盈康已成功转型为科技型的公司了，那为何目前盈康的估值还这么低？2025年，公司审议通过了旨在完善治理与回报机制的相关制度。外延发展方面，公司于2025年上半年完成对长沙珂信肿瘤医院51%股权的收购，旨在进一步夯实在医疗服务领域的肿瘤特色，增厚业绩并增强持续经营能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800008849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2589850227","title":"盈康生命：2025年完成收购长沙珂信肿瘤医院51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2589850227","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589850227?lang=zh_cn&edition=full","pubTime":"2025-12-05 11:48","pubTimestamp":1764906491,"startTime":"0","endTime":"0","summary":"公司去年提出市值管理，请问2025年公司在市值管理方面，做出了哪些具体行动？2025年，公司审议通过了旨在完善治理与回报机制的相关制度。外延发展方面，公司于2025年上半年完成对长沙珂信肿瘤医院51%股权的收购，旨在进一步夯实在医疗服务领域的肿瘤特色，增厚业绩并增强持续经营能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500014118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2588078737","title":"【私募调研记录】瑞博投资调研盈康生命","url":"https://stock-news.laohu8.com/highlight/detail?id=2588078737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588078737?lang=zh_cn&edition=full","pubTime":"2025-12-04 08:04","pubTimestamp":1764806687,"startTime":"0","endTime":"0","summary":"根据市场公开信息及12月3日披露的机构调研信息，知名私募瑞博投资近期对1家上市公司进行了调研，相关名单如下：1）盈康生命 调研纪要：长沙珂信肿瘤医院于2015年9月正式开业，是三级肿瘤专科医院，湖南湘江新区癌症防治中心，省市医保定点单位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025120400003809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2585192618","title":"盈康生命：截至2025年11月20日股东总数为20,395户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585192618","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585192618?lang=zh_cn&edition=full","pubTime":"2025-11-21 15:04","pubTimestamp":1763708659,"startTime":"0","endTime":"0","summary":"证券之星消息，盈康生命(300143)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问11月20日的股东人数多少，谢谢盈康生命回复：尊敬的投资者，您好！截至2025年11月20日，公司股东总数为20,395户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100017211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2584793901","title":"上市公司，再卖一家大型医院！","url":"https://stock-news.laohu8.com/highlight/detail?id=2584793901","media":"医疗器械经销商...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584793901?lang=zh_cn&edition=full","pubTime":"2025-11-20 11:56","pubTimestamp":1763610960,"startTime":"0","endTime":"0","summary":"如本次交易顺利完成，公司将不再持有昆明医科股权，昆明医科将不再纳入公司合并财务报表范围。公开资料显示，昆明医科肿瘤医院是二级肿瘤专科医院，同时是全国连锁专科医院，核定编制床位130张。据企查查信息，上述四家医院为公司旗下的全部医疗资产，这意味着永和智控正在剥离医疗业务。此外有消息称，永和智控曾经还投资过一家厦门永和医科肿瘤医院有限公司，不过目前该医院已显示“注销”状态。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-20/doc-infxzkvh1036058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0259","BK0236","002795","300143"],"gpt_icon":0},{"id":"2583513137","title":"股市必读：盈康生命(300143)股东户数2.09万户，较上期增加1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583513137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583513137?lang=zh_cn&edition=full","pubTime":"2025-11-14 02:26","pubTimestamp":1763058375,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，盈康生命报收于11.15元，上涨0.27%，换手率1.79%，成交量11.46万手，成交额1.26亿元。股本股东变化股东户数变动近日盈康生命披露，截至2025年11月10日公司股东户数为2.09万户，较10月31日增加240.0户，增幅为1.16%。户均持股数量由上期的3.63万股减少至3.59万股，户均持股市值为38.8万元。投资者： 董秘你好，截止到2025年11月10日股东人数是多少？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400000894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768334273606,"stockEarnings":[{"period":"1week","weight":0.1723},{"period":"1month","weight":0.3387},{"period":"3month","weight":0.1849},{"period":"6month","weight":0.3187},{"period":"1year","weight":0.5621},{"period":"ytd","weight":0.336}],"compareEarnings":[{"period":"1week","weight":0.0135},{"period":"1month","weight":0.0641},{"period":"3month","weight":0.0579},{"period":"6month","weight":0.1768},{"period":"1year","weight":0.3094},{"period":"ytd","weight":0.0428}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"盈康生命科技股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"26187人(较上一季度增加28.83%)","perCapita":"24491股","listingDate":"2010-12-09","address":"山东省青岛市城阳区春阳路37号","registeredCapital":"74945万元","survey":"　　盈康生命科技股份有限公司的主营业务是提供以肿瘤为特色的医疗服务以及关键场景、关键设备医疗器械的研发、创新和服务。公司的主要产品是医疗设备及耗材产品、系统开发集成、医疗服务。","listedPrice":36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盈康生命,300143,盈康生命股票,盈康生命股票老虎,盈康生命股票老虎国际,盈康生命行情,盈康生命股票行情,盈康生命股价,盈康生命股市,盈康生命股票价格,盈康生命股票交易,盈康生命股票购买,盈康生命股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}